The Role of Adjuvant Chemotherapy for Patients with Resected Pancreatic Cancer : Systematic Review of Randomized Controlled Trials and Meta-AnalysisBOECK, Stefan; ANKERST, Donna Pauler; HEINEMANN, Volker et al.Oncology. 2007, Vol 72, Num 5-6, pp 314-321, issn 0030-2414, 8 p.Article

Biomarkers for prostate cancer detectionPAREKH, Dipen J; ANKERST, Donna Pauler; TROYER, Dean et al.The Journal of urology. 2007, Vol 178, Num 6, pp 2252-2259, issn 0022-5347, 8 p.Article

Protein Kinase C Inhibition in the Treatment of Mania : A Double-blind, Placebo-Controlled Trial of TamoxifenTOHEN, Mauricio; YILDIZ, Aysegül; GULERYUZ, Sebnem et al.Archives of general psychiatry. 2008, Vol 65, Num 3, issn 0003-990X, 252-253, 255-263 [11 p.]Article

Clinical Score for Nonbacterial Osteitis in Children and AdultsJANSSON, Annette F; MÜLLER, Thomas H; GLIERA, Leonhard et al.Arthritis and rheumatism. 2009, Vol 60, Num 4, pp 1152-1159, issn 0004-3591, 8 p.Article

Progression-Free Survival as a Surrogate Endpointfor Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis from 50 Randomized First-Line TrialsGIESSEN, Clemens; LAUBENDER, Ruediger Paul; ANKERST, Donna Pauler et al.Clinical cancer research (Print). 2013, Vol 19, Num 1, pp 225-235, issn 1078-0432, 11 p.Article

Afamin and Apolipoprotein A-IV: Novel Protein Markers for Ovarian CancerDIEPLINGER, Hans; ANKERST, Donna Pauler; BURGES, Alexander et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 4, pp 1127-1133, issn 1055-9965, 7 p.Article

Prediction of prostate cancer for patients receiving finasteride : Results from the prostate cancer prevention trialTHOMPSON, Ian M; ANKERST, Donna Pauler; CHEN CHI et al.Journal of clinical oncology. 2007, Vol 25, Num 21, pp 3076-3081, issn 0732-183X, 6 p.Article

External validation of the prostate cancer prevention trial risk calculator in a screened populationPAREKH, Dipen J; ANKERST, Donna Pauler; HIGGINS, Betsy A et al.Urology (Ridgewood, NJ). 2006, Vol 68, Num 6, pp 1152-1155, issn 0090-4295, 4 p.Article

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lowerTHOMPSON, Ian M; ANKERST, Donna Pauler; CHEN CHI et al.JAMA, the journal of the American Medical Association. 2005, Vol 294, Num 1, pp 66-70, issn 0098-7484, 5 p.Article

Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mLCANBY-HAGINO, Edith; HERNANDEZ, Javier; BRAND, Timothy C et al.Urology (Ridgewood, NJ). 2007, Vol 70, Num 4, pp 748-752, issn 0090-4295, 5 p.Article

Assessing prostate cancer risk : Results from the prostate cancer prevention trialTHOMPSON, Ian M; ANKERST, Donna Pauler; CHEN CHI et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 8, pp 529-534, issn 0027-8874, 6 p.Article

Obesity, adipokines, and prostate cancer in a prospective population-based studyBAILLARGEON, Jacques; PLATZ, Elizabeth A; LYNCH, Steve et al.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 7, pp 1331-1335, issn 1055-9965, 5 p.Article

Effect of finasteride on the sensitivity of PSA for detecting prostate cancerTHOMPSON, Ian M; CHEN CHI; ANKERST, Donna Pauler et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 16, pp 1128-1133, issn 0027-8874, 6 p.Article

Longitudinal analysis of sexual function reported by men in the prostate cancer prevention trialMOINPOUR, Carol M; DARKE, Amy K; LIPPMAN, Scott M et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 13, pp 1025-1035, issn 0027-8874, 11 p.Article

Quality of life and pain in advanced stage prostate cancer : Results of a southwest oncology group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisoneBERRY, Donna L; MOINPOUR, Carol M; HUSSAIN, Maha H. A et al.Journal of clinical oncology. 2006, Vol 24, Num 18, pp 2828-2835, issn 0732-183X, 8 p.Article